Yanyan Liu, M.D. Ph.D
Henan Cancer Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yanyan Liu, M.D. Ph.D as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05209620 · Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System LymphomaHenan Cancer Hospital · recruiting · Central Nervous System Lymphoma · study director
- Ph1NCT05083208 · PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell LymphomaHenan Cancer Hospital · terminated · Peripheral T-Cell Lymphoma · study director
- Ph2NCT04737889 · Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System LymphomaHenan Cancer Hospital · recruiting · Primary Central Nervous System Lymphoma · study director
- Ph2NCT04668365 · Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell LymphomaHenan Cancer Hospital · suspended · Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation · study director
- Ph2NCT04433156 · VR-CAP in the First-line Treatment for Patients With Marginal Zone LymphomaHenan Cancer Hospital · completed · Marginal Zone Lymphoma · study director
- N/ANCT04263935 · Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in LymphomaHenan Cancer Hospital · recruiting · Lymphoma, Gene Abnormality · study director
- Ph2NCT04214626 · R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell LymphomaHenan Cancer Hospital · completed · Diffuse Large B Cell Lymphoma · study director
- Ph2NCT04067037 · Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's LymphomaHenan Cancer Hospital · active not recruiting · Classical Hodgkin Lymphoma · study director
- Ph2NCT02733380 · Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaHenan Cancer Hospital · unknown · Diffuse Large B-cell Lymphoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.